DMC Best Practices: What Biotechs and Sponsors Should Know  

1 minute read

Published: August 5th, 2025

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise. 

Speakers:
  • Lucy Clark, Statistics Manager
  • Lisa Gibbons, Senior Statistician
  • Matt George (Moderator), Senior Statistician
Learning Points :
  • Share best practices for establishing and running an effective Data Monitoring Committee
  • Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
  • Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials.
Complete the form below to access the recording and slides:

Related articles

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and re...

AI for Automation and Digital Data Flow

AI for Automation and Digital Data Flow

June 24th, 2026 1 minute read

Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s...